BestEx Research Grows Business Development Team, Appoints Managing Director Charlie Whitlock
"Charlie's sterling reputation for serving clients with integrity and dedication aligns with our vision at BestEx Research to deliver the very best for our clients—building lasting partnerships rather than transactional relationships," said
In addition to the appointment of
To learn more about BestEx Research's high-performance, multi-asset execution algorithms offered within the firm's Algorithm Management System (AMS)—including the platform's no-code strategy customization and automation tools, simulation and A/B testing capabilities, order management dashboard, and transaction cost analytics (TCA)—please visit bestexresearch.com.
About BestEx Research
BestEx Research Group LLC is a provider of sophisticated execution algorithms for equities and futures aimed at reducing trading costs for buy-side managers. The firm's cloud-based Algorithm Management System (AMS) combines their execution algorithms with a user-friendly dashboard, transaction cost analysis, customization, and automation in the industry's first multi-asset, independent algorithmic execution platform. BestEx Research also offers sell-side firms a seamless, customizable trading solution for their clients with no coding required. For more information on BestEx Research's mission and products, or to request a product demo, visit www.bestexresearch.com. Please follow BestEx Research on LinkedIn and X.
Media Contact
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/bestex-research-grows-business-development-team-appoints-managing-director-charlie-whitlock-302540578.html
SOURCE BestEx Research
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Invitation to press and analyst conference in Stockholm
- Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD
- Dr. Vein, a Specialist Varicose Vein Clinic in Ho Chi Minh City, Sets Out Its Treatment Pathway for Patients Travelling from the United States
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Credit Suisse, JPMorgan, BofA/Merrill LynchSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share